Sun Pharma Adv Standalone March 2023 Net Sales at Rs 47.69 crore, up 88.95% Y-o-Y
Reported Standalone quarterly numbers for Sun Pharma Advanced Research Company are: Net Sales at Rs 47.69 crore in March 2023 up 88.95% from Rs. 25.24 crore in March 2022. Quarterly Net Loss at Rs. 81.99 crore in March 2023 down 15.4% from Rs. 71.05 crore in March 2022. EBITDA stands negative at Rs. 78.84 crore in March 2023 down 18.88% from Rs. 66.32 crore in March 2022. Sun Pharma Adv shares closed at 194.40 on May 19, 2023 (NSE) and has given -21.04% returns over the last 6 months and -10.08% over the last 12 months.
| Sun Pharma Advanced Research Company | | Standalone Quarterly Results | in Rs. Cr. |
|
Story continues below Advertisement
| Mar'23 | Dec'22 | Mar'22 | | Net Sales/Income from operations | 47.69 | 131.09 | 25.24 | | Other Operating Income | -- | -- | -- | | Total Income From Operations | 47.69 | 131.09 | 25.24 | | EXPENDITURE | | Consumption of Raw Materials | 5.78 | 5.05 | 6.38 | | Purchase of Traded Goods | -- | -- | -- | | Increase/Decrease in Stocks | -- | -- | -- | | Power & Fuel | -- | -- | -- | | Employees Cost | 29.90 | 25.66 | 23.08 | | Depreciation | 2.94 | 3.13 | 2.51 | | Excise Duty | -- | -- | -- | | Admin. And Selling Expenses | -- | -- | -- | | R & D Expenses | -- | -- | -- | | Provisions And Contingencies | -- | -- | -- | | Exp. Capitalised | -- | -- | -- | | Other Expenses | 101.58 | 84.20 | 62.32 | | P/L Before Other Inc. , Int., Excpt. Items & Tax | -92.51 | 13.05 | -69.05 | | Other Income | 10.73 | 0.03 | 0.22 | | P/L Before Int., Excpt. Items & Tax | -81.78 | 13.08 | -68.83 | | Interest | 0.21 | 2.93 | 2.22 | | P/L Before Exceptional Items & Tax | -81.99 | 10.15 | -71.05 | | Exceptional Items | -- | -- | -- | | P/L Before Tax | -81.99 | 10.15 | -71.05 | | Tax | -- | -- | -- | | P/L After Tax from Ordinary Activities | -81.99 | 10.15 | -71.05 | | Prior Year Adjustments | -- | -- | -- | | Extra Ordinary Items | -- | -- | -- | | Net Profit/(Loss) For the Period | -81.99 | 10.15 | -71.05 | | Equity Share Capital | 32.45 | 27.53 | 27.19 | | Reserves Excluding Revaluation Reserves | -- | -- | -- | | Equity Dividend Rate (%) | -- | -- | -- | | EPS Before Extra Ordinary | | Basic EPS | -2.55 | 0.37 | -2.69 | | Diluted EPS | -2.55 | 0.35 | -2.69 | | EPS After Extra Ordinary | | Basic EPS | -2.55 | 0.37 | -2.69 | | Diluted EPS | -2.55 | 0.35 | -2.69 | | Public Share Holding | | No Of Shares (Crores) | -- | -- | -- | | Share Holding (%) | -- | -- | -- | | Promoters and Promoter Group Shareholding | | a) Pledged/Encumbered | | - Number of shares (Crores) | -- | -- | -- | | - Per. of shares (as a % of the total sh. of prom. and promoter group) | -- | -- | -- | | - Per. of shares (as a % of the total Share Cap. of the company) | -- | -- | -- | | b) Non-encumbered | | - Number of shares (Crores) | -- | -- | -- | | - Per. of shares (as a % of the total sh. of prom. and promoter group) | -- | -- | -- | | - Per. of shares (as a % of the total Share Cap. of the company) | -- | -- | -- | | Source : Dion Global Solutions Limited |
|
Discover the latest Business News, Sensex, and Nifty updates. Obtain Personal Finance insights, tax queries, and expert opinions on Moneycontrol or download the Moneycontrol App to stay updated!
